Guidance on Protocol Deviations Related to Shortage of IV Iodinated Contrast (Omnipaque)

May 13, 2022

To Research Teams:

Due to a serious shortage of IV iodinated contrast related to supply chain disruption, the IRB has developed procedures intended to mitigate the potential for IRB reporting of large numbers of deviations from approved protocol procedures. All investigators who oversee studies using contrast should read the guidance for OHRS changes related to protocol deviations linked below, and available on the DF/HCC COVID-19 Updates & Information Page

OHRS Omnipaque Shortage Process

If you have any questions, please contact OHRS@dfci.harvard.edu directly.